Status:
COMPLETED
Cognitive Behavioral Therapy for Adolescent Binge Eating and Loss of Control Eating
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Binge Eating
Eating Disorders in Adolescence
Eligibility:
All Genders
12-17 years
Phase:
NA
Brief Summary
This study will develop and test a cognitive-behavioral intervention for adolescents with binge/loss-of-control eating.
Detailed Description
Youth who engage in binge eating or loss-of-control eating are at high risk for physical and mental health impairment, as well as excess weight gain. As there are few evidence-based treatments for ado...
Eligibility Criteria
Inclusion
- To be included, adolescents must:
- Be in the age range ≥12 years old and ≤17 years old;
- Have a BMI that places them above the 85th percentile based on their age and sex;
- Report 2 episodes of binge/LOC eating (feeling a loss of control while eating) per month for the past 3 months;
- Be otherwise-healthy youth (i.e., no uncontrolled or serious medical conditions);
- Read, comprehend, and write English at a sufficient level to complete study-related materials;
- Be available for participation in the study for 7 months.
Exclusion
- Prospective participants will be excluded if the adolescent:
- Has a medical or psychiatric condition that would require hospitalization or intensive care (e.g., neurological disorder, psychotic disorders, suicidality);
- Has a medical or psychiatric condition that would prohibit them from engaging in behavioral treatment or moderate physical activity (e.g., cardiovascular problems);
- Has uncontrolled medical condition(s) (e.g., uncontrolled diabetes or hypertension);
- Is pregnant or breastfeeding;
- Is taking medication(s) or participating in treatment(s) that could influence weight or appetite;
- Began taking hormonal contraceptives less than 3 months prior;
- Has a developmental or cognitive disorder (e.g., autism spectrum disorder);
- Has a concurrent feeding/eating disorder (e.g., bulimia nervosa); or
- Is participating in another clinical research study.
Key Trial Info
Start Date :
December 30 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 8 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04088097
Start Date
December 30 2019
End Date
January 8 2024
Last Update
October 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale School of Medicine
New Haven, Connecticut, United States, 06520